Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Clinical trial NCT01895335 · COMPLETED
Trial details
- NCT number
- NCT01895335
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-11-01
- Enrollment
- 1001
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.